Prescribing carbonic anhydrase inhibitors to patients with “sulfa” antibiotics allergy: do we dare?
Despite no supporting evidence, a significant number of respondents would avoid CAI in patients with prior SA hypersensitivity. Respondents without glaucoma training, no affiliation with a glaucoma organization, and >10 years in practice are more likely to avoid CAI in patients with type I SA hypersensitivity. Providers should be informed of the low cross-reactivity risk between CAI and SA so more patients may benefit from these drugs.
Authors
- Raquel Quintanilla (ORCID: https://orcid.org/0000-0003-3274-3434)
- Alana L. Grajewski (ORCID: https://orcid.org/0000-0002-7438-4196)
- John McSoley
- Elena Bitrian (ORCID: https://orcid.org/0009-0000-9325-2503)
- Ta Chen Chang (ORCID: https://orcid.org/0000-0003-4827-5014)
- Elizabeth Hodapp
- Arjun Sharma (ORCID: https://orcid.org/0000-0001-9204-856X)
- Luke van Leeuwen
Institutions
- University of Miami (US)
Publication Details
- Journal
- Eye
- Published
- 2025-02-15
- DOI
- https://doi.org/10.1038/s41433-025-03674-9
- Citations
- 1
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.39